Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Autism Biomarker Discovery Program

Principal Investigator

Principal Investigator

Carpenter, Randall

Description

Description

This project aims to identify gene and protein biomarkers that can predict response to autism treatments. Initially, the goal is to identify individuals likely to benefit from treatment with Seaside’s lead compound STX-209 (arbaclofen). At the same time, Seaside will be identifying biomarkers that can flag increased risk for side effects.

Funder

Funder

Autism Speaks

Fiscal Year Funding

Fiscal Year Funding

1999984

Current Award Period

Current Award Period

2013-2013

Strategic Plan Question

Strategic Plan Question

Question 2: How Can I Understand What Is Happening?

Strategic Plan Objective

Strategic Plan Objective

Green dot: Objective has greater than or equal to the recommended funding. 2LB. Launch at least three studies which evaluate the applicability of ASD phenotype and/or biological signature findings for performing diagnosis, risk assessment, or clinical intervention by 2015. IACC Recommended Budget: $7,200,000 over 5 years.

Project Link

Project Link

Autism Biomarker Discovery Program (External web link)

Institution

Institution

Seaside Therapeutics

State/Country

State/Country

Massachusetts

Project Number

Project Number

n/a

Federal or Private?

Federal or Private?

Private

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

N/A

 
Back to Top